Clinical Trials Browser

INDUSTRY × grapiprant × Clear all

NCT03658772 2023-10-24

Grapiprant and Pembrolizumab in Patients With Advanced or Progressive MSS Colorectal Cancer

Phase 1 Completed

Gastrointestinal

Microsatellite Stable Colorectal Cancer

NCT03696212 2021-02-21

Grapiprant (ARY-007) and Pembrolizumab in Patients With Advanced or Metastatic Post-PD-1/L1 NSCLC Adenocarcinoma

Phase 1/2 Terminated

Non-small Cell Lung Cancer Adenocarcinoma